Ignite Creation Date:
2025-12-24 @ 10:59 PM
Ignite Modification Date:
2026-01-05 @ 5:31 PM
Study NCT ID:
NCT03686969
Status:
TERMINATED
Last Update Posted:
2021-04-23
First Post:
2018-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating Efficacy and Safety of Octanorm in Patients With Dermatomyositis
Sponsor:
Octapharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-02
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-29
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-31
First Submit QC Date:
None
Study First Post Date:
2018-09-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-03-12
Results First Submit QC Date:
None
Results First Post Date:
2021-04-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-22
Last Update Post Date:
2021-04-23
Last Update Post Date Type:
ACTUAL